跳至主要内容
临床试验/NCT02244775
NCT02244775Approved For Marketing不适用

Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device

Hospital for Special Surgery, New York1 个研究点 分布在 1 个国家开始时间: 2014年9月19日最近更新:
适应症

试验速览

阶段
不适用
状态
Approved For Marketing
发起方
试验地点
1

研究概览

简要总结

The purpose of this study is to allow patients to undergo surgery with the SR™ MCP (Metacarpophalangeal) Implants for finger arthritis. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of device.

详细描述

The purpose of this IRB approved study is to allow patients to undergo surgery with the SR™ MCP (Metacarpophalangeal) Implants. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of device. Use of the SR™ MCP is approved for humanitarian use by the FDA when either the patient is in need of a revision of failed MCP prothesis(es) or the patient expects to place his/her hand under loading situation which preclude the use of an alternative implant in the painful osteo-arthritic and post traumatic arthritic MCP joint.

研究设计

研究类型
Expanded Access

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient is in need of a revision of failed MCP prosthesis(es)
  • patient expects to place his/her hands under loading situations which preclude the use of an alternative implant in the painful osteo-arthritic and post traumatic arthritic MCP joint

排除标准

  • patient is not in need of a revision of a failed MCP prothesis(es)
  • patient is eligible to use an alternative implant

研究者

发起方
Hospital for Special Surgery, New York
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验